Co-Authors
This is a "connection" page, showing publications co-authored by Winfried Kern and Jonathan Rilinger.
Connection Strength
0.221
-
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):470.
Score: 0.221
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.